Venture Capital Investors

LAV Fund

LAV Fund is a VC investing group that backs technology-based companies.

Venture Investor Overview

Contact Information

Background Information

Overview

LAV Fund refers to the venture capital funds managed by Lilly Asia Ventures (LAV), a leading biomedical investment firm. Established in 2008 as a corporate venture subsidiary of Eli Lilly, LAV became an independent entity in 2011. The firm specializes in investing in biopharmaceuticals, human therapeutics, medical devices, and diagnostics, with a focus on companies developing breakthrough products to treat diseases and improve human health.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

5/7/2025

Transaction History

Our records indicate that LAV Fund invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Contact

First Last

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

LAV Fund has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know.

Browse more venture capital investors:

Lauxera Capital Partners | Laveer Growth Capital

Share this article

About Our VC Investors Database

This VC firm profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary